AFT Pharmaceuticals Innovates Scar Treatment Solutions
Company Announcements

AFT Pharmaceuticals Innovates Scar Treatment Solutions

AFT Pharmaceuticals Ltd. (AU:AFP) has released an update.

AFT Pharmaceuticals has announced a collaboration with Massey Ventures and the Gillies McIndoe Research Institute to develop a new topical treatment for keloid and hypertrophic scars. The partnership aims to create the first effective non-invasive treatment option for these often disfiguring and painful scars. This collaboration builds upon their previous successful work on a treatment for strawberry birthmarks and further extends AFT’s R&D portfolio, emphasizing their commitment to international growth.

For further insights into AU:AFP stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App